Brief: AB Science Announces Capital Increase For An Amount Of 15 Million Euros
24/04/2023 07:12
April 24 (Reuters) - AB Science SA ABS.PA :
* AB SCIENCE ANNOUNCES THE SUCCESS OF ITS CAPITAL INCREASE
BY
PRIVATE PLACEMENT FOR AN AMOUNT OF 15 MILLION EUROS
* PROCEEDS OF CAPITAL INCREASE WILL PROVIDE AB SCIENCE WITH
ADDITIONAL RESOURCES NECESSARY TO FINANCE ITS ACTIVITIES OVER
NEXT TWELVE MONTHS
* RAISED FUNDS WILL BE USED FOR CLINICAL DEVELOPMENT OF
MASITINIB
IN AMYOTROPHIC LATERAL SCLEROSIS AND OTHER ORPHAN INDICATIONS
* ISSUE PRICE OF NEW SHARES HAS BEEN SET AT 5.75 EUROS (0.01
EURO
PAR VALUE AND 5.74 EUROS ISSUE PREMIUM)
Source text for Eikon: ID:nGNEd9r35
Further company coverage: ABS.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on AB Science SA
See all newsBrief: AB Science Temporarily Halts Europe Clinical Trials Ahead Of Strategic Reorganization
Brief: AB Science Says FDA Granted Status Of Minor Use In Major Species For Masivet
Brief: AB Science Says Co Received Japanese Patent Protection To Use Masitinib In Progressive MS Until 2041
Brief: AB Science Phase 1 AML Study Of AB8939 Shows 100% Partial Response Rate
Brief: AB Science Receives Notice Of Allowance For European Patent Covering Masitinib Until 2040 In Treatment Of Sickle Cell Disease